Evaluating the potential toxicity of chemicals is an important part of the drug development process. Optimizing a data set that provides quality …
By 2025, 36% of world data will be healthcare data. (Yes, thirty-six percent!). Considering this statistic, now more than ever, it is …
The nitrosamine crisis first erupted in July 2018, when the FDA announced voluntary recall of several drugs containing Valsartan: a medicine used …
Hello, my name is Fabrizio Campo. I work in the Software Delivery department at Lhasa Limited, as a Junior Software Developer. My role aims …
With technical input from Andrew Thresher. Would your toxicology assessments benefit from free access to long-term carcinogenicity study data? The Lhasa Carcinogenicity …
When assessing the mutagenic potential of drug impurities in silico, the ICH M7 guideline states that two complementary (Q)SAR prediction methodologies should be …